Penobscot Investment Management Company 13F: Cuts ISRG Stake by $519K

Key Points

  • Penobscot Investment Management Company reported a 12.6% decrease in its position in Intuitive Surgical, reducing its stake to 8,830 shares.
  • The fund's total reported value in Intuitive Surgical is now approximately $3.59 million, representing 0.56% of its overall portfolio.
  • The stock recently traded around $445.89, which is about 1.3% below its closing price of $451.63 on the filing date.

Get Intuitive Surgical text alerts

We text you when insiders, Congress, analysts or big funds move on $ISRG.

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Not investment advice. TradeTexts is not a registered investment adviser, and this automated Intuitive Surgical, Inc. alert may contain errors. Disclosures

On October 26, 2026, Penobscot Investment Management Company reduced its holdings in Intuitive Surgical, Inc. (ISRG) by 1,276 shares. This change brings the fund's total stake to 8,830 shares valued at approximately $3,590,543, according to its latest Form 13F filing with the SEC.

ISRG Intuitive Surgical, Inc.
$451.63 -19.64% year to date
Daily close · Oct 26, 2026
13F track record

Penobscot Investment Management Company vs. the S&P 500

YTD return +4.12% hypothetical
All-time return +4.12% S&P 500 +6.30%
vs. S&P 500 -2.18% behind the index

Hypothetical returns from Penobscot Investment Management Company's disclosed trades, not real profit or advice. How we model this.

What Changed in Penobscot Investment's Intuitive Surgical Position

Penobscot cut its position by 1,276 shares, reflecting a 12.6% decrease. This adjustment comes as the fund continues to manage its investments amid changing market dynamics.

Where Intuitive Surgical Fits in Penobscot Investment's Portfolio

Intuitive Surgical now makes up 0.56% of Penobscot's total reported portfolio, which includes 322 positions.

Other Institutional Activity in Intuitive Surgical

Foster Victor Wealth Advisors increased its holdings in Intuitive Surgical by 2,915 shares, bringing its total to 22,749 shares worth about $9,854,613.

Intuitive Surgical, Inc. Stock Down 1.4%

As of October 28, 2026, Intuitive Surgical's stock traded around $445.89, which is about 1.3% below its closing price of $451.63 on October 26. The stock is currently above its 50-day moving average by 12.3% and above its 200-day moving average by 2.4%, but it remains 26.2% below its 52-week high of $603.88.

Recent Earnings

Intuitive Surgical reported trailing twelve-month revenue of approximately $11.58 billion, with a net margin of 25.5%. The next earnings report is scheduled for January 21, 2027.

Insider Buying and Selling at Intuitive Surgical, Inc.

Several insiders sold shares on October 23, 2026. Fredrik Widman, VP Corporate Controller, sold 4,047 shares at an average price of $453.21, totaling about $1.83 million. Craig H. Barratt, Director, sold 1,150 shares for about $510,370, while Gary S. Guthart, Director, sold 20,095 shares for approximately $9.1 million. Patricia L. Wadors, SVP Chief Human Resources Officer, sold 1,078 shares for about $478,416.

Analysts Set New Price Targets

On October 21, 2026, several firms maintained their ratings for Intuitive Surgical. Leerink Partners maintained an Outperform rating with a target of $503, while JP Morgan kept an Overweight rating with a target of $475. Wells Fargo also maintained an Overweight rating with a target of $486.

About Intuitive Surgical

Intuitive Surgical, Inc. develops and sells robotic surgical systems, enabling doctors to perform minimally invasive surgeries. The company's innovative technology aims to improve patient outcomes and enhance the quality of care.

Bottom Line

Investors should keep an eye on the upcoming earnings report on January 21, 2027, and any further filings from Penobscot Investment Management Company as they adjust their portfolio strategies.

Source: Penobscot Investment Management Company's 13F filing on $ISRG (Oct 26, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Written by software, not financial advice. How we make alerts

Get $ISRG trade alerts by text

SMS Terms

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Full terms and conditions